Ann: Quarterly Activities & Cash Flow Report, page-6

Did you not read the Ann today about the revenue below? 1.3m revenue invoiced for this qtr due for payment next qtr.
Production cost is associated with sales order last year total 1.9m compared to completed orders this qtr 1.3m, where did you get the 700% up figure from? It also explains the 4M outflow for operations and investment is only 0.5m higher than estimate for the reason stated.

This primarily related to the increased production costs and inventory to support rapidly growing sales of the Nano for which customer receipts will occur next quarter.

Highlights for the Quarter• Carestream DRX Revolution Nano orders grew substantially in response to COVID-19 demand• First major Australian purchase orders of Nano for NSW Govt agencies and The Alfred - $1.0 million• Total Orders of Nano for the Quarter of $3.0 million and $0.6 million post Quarter end• $1.3 million of revenues invoiced this Quarter for completed Nanos – due for payment next quarter• Major expansion of production to meet increasing Nano sales demand and reduce delivery times• Rover for US military ready to commence safety testing to support FDA 510(k) dossier• Recertification of Micro-X’s Quality Management System under ISO 13485• Closing cash balance of $8.1 million